Clover Health Investments Corp (NASDAQ: CLOV) started the day on Thursday, with a price decrease of -7.16% at $2.66, before settling in for the price of $2.87 at the close. Taking a more long-term approach, CLOV posted a 52-week range of $0.61-$3.82.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 52.25%. Meanwhile, its Annual Earning per share during the time was -585.84%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 71.35%. This publicly-traded company’s shares outstanding now amounts to $393.27 million, simultaneously with a float of $375.64 million. The organization now has a market capitalization sitting at $1.32 billion. At the time of writing, stock’s 50-day Moving Average stood at $2.04, while the 200-day Moving Average is $1.19.
Clover Health Investments Corp (CLOV) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Healthcare Plans Industry. Clover Health Investments Corp’s current insider ownership accounts for 24.49%, in contrast to 14.74% institutional ownership. According to the most recent insider trade that took place on Aug 09 ’24, this organization’s Director bought 531,700 shares at the rate of 1.88, making the entire transaction reach 999,596 in total value, affecting insider ownership by 1,409,267. Preceding that transaction, on Jun 17 ’24, Company’s Director bought 877,567 for 1.14, making the whole transaction’s value amount to 1,000,426. This particular insider is now the holder of 877,567 in total.
Clover Health Investments Corp (CLOV) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
Clover Health Investments Corp’s EPS increase for this current 12-month fiscal period is 71.35% and is forecasted to reach -0.13 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 19.10% through the next 5 years, which can be compared against the -585.84% growth it accomplished over the previous five years trading on the market.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Let’s observe the current performance indicators for Clover Health Investments Corp (CLOV). The Stock has managed to achieve an average true range (ATR) of 0.30. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.78.
In the same vein, CLOV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.26, a figure that is expected to reach -0.04 in the next quarter, and analysts are predicting that it will be -0.13 at the market close of one year from today.
Technical Analysis of Clover Health Investments Corp (CLOV)
If we take a close look at the recent performances of Clover Health Investments Corp (NASDAQ: CLOV), its last 5-days Average volume was 14.0 million that shows progress from its year to date volume of 8.1 million. During the previous 9 days, stock’s Stochastic %D was recorded 16.97% While, its Average True Range was 0.33.
Raw Stochastic average of Clover Health Investments Corp (CLOV) in the period of the previous 100 days is set at 64.01%, which indicates a major rise in contrast to 15.07% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 118.18% that was higher than 97.43% volatility it exhibited in the past 100-days period.
